Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1449 per EA under NDC 33342010409. Its NADAC has been published 450 times since Jan 11, 2017.
FDA first approved this application on May 17, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342010409
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA203359FDA Approved
5/17/2016
TE Code
AB
On Market Since
6/14/2016
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 450 times since Jan 11, 2017, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1449 per EA |
|---|---|
| All-time high | $0.3285 (Jan 11, 2017) |
| All-time low | $0.1136 (Nov 20, 2024) |
| Median price | $0.1681 |
| Average price | $0.1776 |
| Largest weekly change | -26.7% (Nov 20, 2024) |
| Weeks tracked | 450 |
| Tracking since | Jan 11, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+12.3%
5Y
-9.8%
All
-55.9%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.1449 per EA (NDC 33342010409), effective Aug 20, 2025.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 55.9%. It has been tracked across 450 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Jan 11, 2017, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.3285 (Jan 11, 2017), with a median of $0.1681 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1285 per EA — about 11% below QUETIAPINE FUMARATE 300 MG TAB.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 33342010409) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.